Theranos Founder Sentenced to 11 Years in Prison
November 18, San Jose, CA: Theranos founder Elizabeth Holmes has been sentenced to 135 months (11.25 years) in prison by U.S. District Judge Edward Davila.
Holmes, who was found guilty in January on three counts of investor fraud and one count of conspiracy to commit fraud related to her blood-testing startup, faced up to 20 years in prison for each guilty count. Her sentence will begin on April 27, 2023.
Prosecutors asked for a 15-year sentence. Holme’s defense team sought no more than 18 months in prison. Per reporter Ethan Baron, who covered the sentencing live on his Twitter feed, Judge Davila declined to consider patient harm in the sentencing, as Holmes was acquitted of all charges related to patient harm, nor did he consider the full investor losses of $700 million, stating that there was “insufficient evidence to show that the defendant’s fraud and conspiracy was the sole cause of the company’s collapse.”
He instead based the sentence on Holmes defrauding 10 or more victims for a loss of $121 million.
Ramesh “Sunny” Balwani, former president and chief operating officer of Theranos, who was found guilty on 12 counts of fraud earlier this year, is scheduled to be sentenced next month.
Related Articles
-
Balwani was found guilty on 10 counts of wire fraud and two counts of conspiracy to commit wire fraud for misleading investors about the financial health of the healthcare startup. He faced up to 20 years in prison for each…
-
The CERSI program was established to foster robust and innovative approaches to advance regulatory science through collaborative interactions with FDA scientific experts.
-
Balwani was charged with 10 counts of wire fraud and two counts of conspiracy to commit wire fraud for misleading investors.
-
The increase in global regulatory demands for medical devices has presented new challenges for regulatory affairs and intelligence teams. On May 16-17, The MedTech Regulatory Intelligence Summit will bring together regulatory professionals, device developers and regulators to look at current…
About The Author
MedTech Intelligence Staff
The MedTech Intelligence staff consists of freelance journalists and industry contributing writers with decades of experience in covering medical device issues under the categories of business, market trends, product development, quality, regulatory, and operations.
You can contact our writing staff via our Contact Page.